Smith Group Asset Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-15
| Closed | -$2K | – | 383 |
|
|
2021
Q2 | $2K | Hold |
15
| – | – | ﹤0.01% | 359 |
|
|
2021
Q1 | $2K | Sell |
15
-433
| -97% | -$57.7K | ﹤0.01% | 325 |
|
|
2020
Q4 | $48K | Hold |
448
| – | – | ﹤0.01% | 220 |
|
|
2020
Q3 | $62K | Buy |
+448
| New | +$62K | ﹤0.01% | 211 |
|
|
2016
Q1 | – | Sell |
-10,785
| Closed | -$870K | – | 491 |
|
|
2015
Q4 | $870K | Sell |
10,785
-1,709
| -14% | -$138K | 0.03% | 179 |
|
|
2015
Q3 | $867K | Sell |
12,494
-3
| -0% | -$208 | 0.03% | 173 |
|
|
2015
Q2 | $1.22M | Buy |
12,497
+250
| +2% | +$24.5K | 0.04% | 164 |
|
|
2015
Q1 | $1.2M | Buy |
12,247
+5,448
| +80% | +$533K | 0.04% | 167 |
|
|
2014
Q4 | $749K | Sell |
6,799
-684
| -9% | -$75.4K | 0.03% | 191 |
|
|
2014
Q3 | $885K | Sell |
7,483
-26
| -0.3% | -$3.08K | 0.03% | 182 |
|
|
2014
Q2 | $974K | Buy |
+7,509
| New | +$974K | 0.04% | 181 |
|